Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History TARA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics TARA

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Protara Therapeutics Inc

TARA
Current price
2.89 USD +0.11 USD (+3.96%)
Last closed 2.78 USD
ISIN US74365U1079
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 111 501 696 USD
Yield for 12 month +38.28 %
1Y
3Y
5Y
10Y
15Y
TARA
21.11.2021 - 28.11.2021

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy for patients receiving parenteral nutrition and fluids. The company is headquartered in New York, New York. Address: 345 Park Avenue South, New York, NY, United States, 10010

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

22.17 USD

P/E Ratio

Dividend Yield

Financials TARA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures TARA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-341 000 USD

Current Quarter

Last Quarter

EBITDA -51 095 000 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -27.16 %
PEG Ratio
Return On Equity TTM -41.88 %
Wall Street Target Price 22.17 USD
Revenue TTM
Book Value 4.11 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.49 USD
Diluted Eps TTM -1.49 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation TARA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.74
Price Book MRQ 0.70

Technical Indicators TARA

For 52 Weeks

1.60 USD 6.88 USD
50 Day MA 3.25 USD
Shares Short Prior Month 2 184 268
200 Day MA 3.59 USD
Short Ratio 7.94
Shares Short 2 203 964
Short Percent 5.86 %